TS-142
TS-142 is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects
A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.
Late Phase II Study of TS-142 in Patients with Insomnia
A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects
Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder
Clinical Trials (8)
A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects
A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.
Late Phase II Study of TS-142 in Patients with Insomnia
A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects
Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder
A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects
Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole)
A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy Participants
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8